Jupiter Life Line Hospitals Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 5,912,080 (50%) | — | ₹43,454 Cr |
| NII (HNI) | — | 1,773,625 (15%) | — | ₹13,036 Cr |
| Retail | — | 4,138,458 (35%) | — | ₹30,418 Cr |
| Σ Total | — | 11,824,163 (100%) | — | ₹869,076 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 20 | ₹14,700 |
| Retail (Max) | 13 | 260 | ₹191,100 |
| S-HNI (Min) | 14 | 280 | ₹205,800 |
| B-HNI (Min) | 67 | 1,340 | ₹984,900 |
Financial Statements Amount in Crore
| Metric | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 |
|---|---|---|---|
| Revenue | 490 | 737 | 903 |
| Profit After Tax | -2 | 51 | 73 |
| Net Worth | 246 | 288 | 364 |
| Total Assets | 789 | 909 | 986 |
| Total Borrowing | 426 | 495 | 469 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Repayment/pre-payment, in full or part, of borrowings availed from banks by the Company and Material Subsidiary;and – 510.16
- 2 General corporate purposes – 1.16
Company Overview
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.
Jupiter Life Line Hospitals has been operating as a corporate quaternary care healthcare service provider in the western regions of India and currently operates three hospitals under the "Jupiter" brand in Thane, Pune, and Indore, with a total operational bed capacity of 1194 beds, and 1,306 doctors including specialists, physicians, and surgeons, as of March 31, 2023. The company is currently developing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to accommodate over 500 beds and has commenced construction in April 2023.
According to the CRISIL Report, the company's Thane and Indore hospitals are amongst the few hospitals in the western region of India to provide neuro-rehabilitation services through a dedicated robotic and computer-assisted neuro-rehabilitation center. Additionally, it operates one of the few multi-organ transplant centers in Thane. All the hospitals in Thane, Pune, and Indore have been certified by the National Accreditation Board for Hospitals & Healthcare Providers (NABH) and have been accredited in the field of medical testing by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
The company's inpatient and outpatient revenue is diversified across hospitals with Thane, Pune, and Indore hospitals accounting for 54.18%, 34.03%, and 11.79%, respectively, of the revenue from operations in Fiscal 2023.